Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 90,066,890
- Share change
- -307,495
- Total reported value
- $56,742,224
- Price per share
- $0.63
- Number of holders
- 26
- Value change
- -$435,632
- Number of buys
- 8
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
73,114,592
|
$85,544,073 | — | 31 Mar 2024 | |
| Matthew Rizzo |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Michael Eggenberg |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
5.5%
|
7,647,873
|
$8,948,011 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.9%
|
4,000,000
|
$4,680,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,548,312
|
$1,811,525 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.55%
|
763,310
|
$893,000 | — | 31 Mar 2024 | |
| AMH Equity Ltd |
13F
|
Company |
0.36%
|
500,000
|
$585,000 | — | 31 Mar 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.27%
|
378,206
|
$442,501 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
368,500
|
$431,145 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.26%
|
367,391
|
$429,847 | — | 31 Mar 2024 | |
| Juniper Investment Company, LLC |
13F
|
Company |
0.25%
|
348,399
|
$407,627 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
316,158
|
$370,048 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
238,605
|
$279,168 | — | 31 Mar 2024 | |
| Jeffrey J. Peters |
3/4/5
|
Director |
—
class O/S missing
|
448,546
|
$273,209 | — | 15 Aug 2022 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.15%
|
212,024
|
$248,068 | — | 31 Mar 2024 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.09%
|
120,326
|
$140,781 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.08%
|
115,548
|
$135,191 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
65,453
|
$76,580 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
58,666
|
$68,639 | — | 31 Mar 2024 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.03%
|
37,500
|
$43,875 | — | 31 Mar 2024 | |
| Midwest Professional Planners, LTD. |
13F
|
Company |
0.03%
|
35,744
|
$41,820 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
29,000
|
$33,930 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.02%
|
25,200
|
$29,484 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
22,266
|
$26,051 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
15,962
|
$18,676 | — | 31 Mar 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
14,879
|
$17,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
13,956
|
$16,329 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
8,443
|
$9,878 | — | 31 Mar 2024 | |
| Towne Trust Company, N.A |
13F
|
Company |
0%
|
2,500
|
$2,925 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,262
|
$2,647 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,275
|
$1,492 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
1,132
|
$1,324 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
514
|
$1,000 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
377
|
$441 | — | 31 Mar 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
12
|
$11 | — | 31 Mar 2024 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q2 2024
As of 30 Jun 2024,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,066,890 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Altium Capital Management LP, Nantahala Capital Management, LLC, VANGUARD GROUP INC, Juniper Investment Company, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Crescent Grove Advisors, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
33
Q2 2024 holders
26
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.